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Edited by Berend WieringaAbstract Huntingtin interacting protein-1 (Hip1) is known to
be associated with the N-terminal domain of huntingtin.
Although Hip1 can induce apoptosis, the exact upstream signal
transduction pathways have not been clariﬁed yet. In the present
study, we examined whether activation of intrinsic and/or extrin-
sic apoptotic pathways occurs during Hip1-mediated neuronal
cell death. Overexpression of Hip1 induced cell death through
caspase-3 activation in immortalized hippocampal neuroprogen-
itor cells. Interestingly, proteolytic processing of Hip1 into par-
tial fragments was observed in response to Hip1 transfection and
apoptosis-inducing drugs. Moreover, Hip1 was found to directly
bind to and activate caspase-9. This promoted cytosolic release
of cytochrome c and apoptosis-inducing factor via mitochondrial
membrane perturbation. Furthermore, Hip1 could directly bind
to Apaf-1, suggesting that the neurotoxic signals of Hip1 trans-
mit through the intrinsic mitochondrial apoptotic pathways and
the formation of apoptosome complex.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Huntington disease; Huntingtin; Hip1; Caspase;
Mitochondria; Apoptosome1. Introduction
Huntington disease (HD) is an autosomal dominant disease
characterized by selective neuronal loss primarily in the stria-
tum and cortex. HD results in the expansion of the polygluta-
mine tract in the huntingtin (HT) protein [1–3]. Although HT
was discovered 10 years ago, its function is still not fully under-
stood [4]. However, many proteins that interact with HT have
been identiﬁed [5,6]. These HT-interacting proteins provide
valuable clues into elucidate the function of HT and the path-
ogenesis of HD.
Huntingtin-interacting protein 1 (Hip1) is one protein
known to interact with HT. Hip1 interacts with the amino ter-
minus of HT, weakly binds to the mutant HT, and is highlyAbbreviations: AIF, apoptosis-inducing factor; HD, Huntington dis-
ease; Hip1, huntingtin interacting protein 1; Hippi, Hip1-protein int-
eractor; HT, huntingtin; PBS, phosphate-buﬀered saline
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doi:10.1016/j.febslet.2006.08.076expressed in neurons [7]. Hip1 is an ortholog of the yeast pro-
tein Sla2p, which is important for the assembly and function of
the cytoskeleton and endocytosis in Saccharomyces cerevisiae
[7,8]. Several studies have demonstrated that Hip1 binds to
clathrin, a-adaptin, and AP-2 [9,10]. Hip1 likely interacts with
these proteins to form a protein complex that is involved in
clathrin-mediated endocytosis [11]. Hip1 knockout mice show
neurological deﬁcits. Cultured neurons from Hip1 knockout
mice have a defect in clathrin-mediated internalization of
AMPA receptors [12].
DNA fragmentation has been observed in neurons in vul-
nerable regions of HD brains, suggesting that cell death in
HD occurs through apoptosis [13]. This apoptotic cascade
can be triggered through two major pathways: the receptor-
mediated extrinsic pathway and the mitochondrial intrinsic
pathway [14,15]. The receptor-mediated extrinsic pathway is
activated by extracellular signals such as members of the
tumor necrosis factor family. The mitochondrial intrinsic
pathway can be activated by stress such as DNA damage,
hypoxia, and loss of survival signals. Mitochondrial damage
results in cytochrome c release and formation of the apopto-
some, a multimeric protein complex containing Apaf-1,
cytochrome c, and caspase-9 [16,17]. Once bound to the
apoptosome, caspase-9 is activated, which triggers a cascade
of eﬀector caspase activation and proteolysis, leading to
apoptotic cell death.
There are conﬂicting data concerning the inﬂuence of Hip1
on cellular survival (see review [18]). However, overexpression
of Hip1 results in rapid caspase 3-dependent cell death in
certain cells [19]. Upstream events leading to Hip1-induced
neuronal cell death have not been clariﬁed and the reported
pro-apoptotic activity of Hip1 is independent of caspase-8,
but is signiﬁcantly inhibited by the anti-apoptotic protein Bcl-
xL[19]. This implicates the involvement of the intrinsic apopto-
tic pathway in Hip1-induced cell death. Our recent report that
dual speciﬁcity protein kinase Dyrk1A selectively phosphory-
lates Hip-1 during neuronal diﬀerentiation of embryonic hippo-
campal neuroprogenitor (H19-7) cells, which results in the
blockade of Hip-1-mediated neuronal cell death [20], also sup-
ports the pro-apoptotic role of Hip1 in neuronal cells. In the
present study, we examined the signal transduction pathways
leading to Hip1-induced neuronal cell death. Our study focuses
on the functional relationship between Hip1 and intrinsic/
extrinsic apoptotic pathways, and the alteration of mitochon-
drial apoptotic eﬀectors. Overexpression of Hip1 induced cell
death via the activation of intrinsic apoptotic pathways andblished by Elsevier B.V. All rights reserved.
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generation of its digested fragment, in H19-7 cells.Hip1 (fmol)
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Fig. 1. Transfection of Hip1 induced neuronal cell death. (A) H19-7
cells were transiently transfected for 24 h with the indicated amounts
of Hip1 DNA. Cell viability was measured using the MTT extraction
assay. (B) Cells were mock-tranfected or transfected for 24 h with 3 lg
of plasmid encoding Hip1. The cells were either left untreated or
treated with 1 lM staurosporine (STS or S) or 100 lM etoposide (ETO
or E) for 12 h. Cell viability of each sample was measured by using
MTT extraction assay (CON- mock-transfected; Hip1, Hip1 alone;
ETO, ETO-treated mock-transfected cells; STS, STS-treated mock-
transfected cells; H + E, ETO-treated Hip1 cells; H + S, STS-treated
Hip1 cells; ***P < 0.001 vs. control, **P < 0.01, *P < 0.05).2. Materials and methods
2.1. Cell culture and DNA transfection
All culture media and antibiotics were purchased from Invitro-
gen. Conditionally immortalized H19-7 cells originated from rat
embryonic hippocampal neurons were generated and maintained
as described previously [20,21]. DNA transfection was performed
using LipofectAMINE plus reagent (Invitrogen), according to the
manufacturer’s instructions. The total amount of DNA transfected
in each individual sample was adjusted using parental empty vector
DNA.
2.2. Plasmids and antiserum
The mammalian expression constructs encoding Hip-1 (pCMV-Hip-
1), wild type huntingtin with 16 CAG repeats and polyclonal anti-Hip-
1 antibodies were provided by M.R. Hayden (University of British
Columbia, Vancouver, Canada). The mammalian construct encoding
Myc-tagged Hip1 was prepared by PCR of the coding sequence of
Hip1 and insertion into pcDNA3.1-Myc-His-(+) vector, and conﬁrmed
by DNA sequencing. A prokaryotic expression plasmid encoding
bacterially recombinant GST-Hip1 was constructed by inserting the
PCR product of wild type Hip1 sequence into pGEX-4T-1 vector
(Amersham Biosciences). Bacterially expressed GST and GST-Hip1
were prepared by using Bulk GST puriﬁcation module (Amersham
Biosciences).
2.3. Assessment of cell viability
Quantiﬁcation of cell survival was performed using the tetrazolium
salt extraction method, as described previously [22]. Statistical analyses
were performed with the aid of the StatView II program (Abacus Con-
cepts, Berkeley, CA). Data were analyzed by one-way analysis of var-
iance. Preplanned comparisons with controls were performed using the
Dunnett’s t-test.
2.4. Western blot analysis and immunoprecipitation
To prepare the cell lysates, cells were rinsed twice with ice-cold
phosphate-buﬀered saline (PBS) and then solubilized in lysis buﬀer
(20 mM Tris, pH 7.9, containing 1.0% Triton X-100, 1 mM Na3VO4,
137 mM NaCl, 1 lg/ml leupeptin, 200 lM phenylmethylsulfonyl ﬂuo-
ride (PMSF), 1 lg/ml aprotinin, 1 mM, 1 mM EGTA, 10 mM NaF,
1 mM tetrasodium pyrophosphate, 5 mM Na2EDTA, 10% glycerol
and 1 mM b-glycerophosphate). The cells were removed by scraping,
and the supernatants were collected after centrifugation for 15 min at
14000 · g at 4 C. The immunoprecipiatation and Western blot analy-
ses were performed as described previously [20].
2.5. Caspase-3 assay
The caspase assay was performed using the ApoAlert Caspase-3
Assay Protocol (Clontech). After 2 h incubation at 37 C, the samples
were measured using a ﬂuorescence plate reader FL 600 (Bio-Tek
Instruments, Winooski, VT) at an excitation wavelength of 390 nm
and an emission of 505 nm in a 96-well plate.
2.6. Analysis of mitochondrial membrane potential
The mitochondrial membrane potential was assessed by the JC-1
staining method. The dye, existing as a monomer in solution and emit-
ting green ﬂuorescence (525 nm), can assume a dimeric conﬁguration
emitting red ﬂuorescence (590 nm) in a reaction driven by the mitochon-
drial membrane potential. Thus, red ﬂuorescence from JC-1 indicates
intact mitochondria, whereas green ﬂuorescence shows monomeric
JC-1 that remained unprocessed due to the breakdown of membrane
potential. H19-7 cells were adjusted to a density of 0.2 · 106/ml, trypsin-
ized, washed in PBS, resuspended in 1 ml medium, stained with 5 mg/ml
JC-1 (Invitrogen) for 30 min at 37 C (with 5% CO2 in the dark). Cells
were then washed twice in PBS and resuspended in 0.5 ml PBS. Analysis
of ﬂuorescence was performed by FACS scan (FASC Calibur, BD
Biosciences). The change of mitochondrial potential was assessed by
measuring the amounts of JC-1 green (uncoupled mitochondria anddetector FL-1) or red (intact mitochondria and detector FL-2) ﬂuores-
cence.
2.7. Subcellular fractionation
Cells were washed with ice-cold PBS and resuspended in isotonic
buﬀer (10 mM HEPES, pH 8.0, 250 mM sucrose, 1 mM EDTA, and
1 mM EGTA,) supplemented with protease inhibitors containing
2 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin, and homoge-
nized in a Dounce homogenizer on ice. Cells were then centrifuged
at 13000 · g for 20 min at 4 C. Cellular fractionation analysis was
performed to detect the cytosolic release of cytochrome c from mito-
chondria, as previously described [23]. Protein contents were measured
using a Bio-Rad protein assay kit.3. Results
3.1. The overexpression of Hip1 induces neuronal cell death
According to a previous report, the overexpression of Hip1
induced cell death in HEK 293 cells [19]. In order to conﬁrm
S.A. Choi et al. / FEBS Letters 580 (2006) 5275–5282 5277that this also occurs in neuronal cells conditionally immortal-
ized hippocampal H19-7 cells were transiently transfected with
a plasmid encoding Hip1 and the change of cell viability was
measured after 24 h by means of MTT extraction method.
As shown in Fig. 1A, overexpression of Hip1 decreased cell
viability compared with mock-transfected cells.
We then examined eﬀects of apoptosis-inducing drugs etopo-
side and staurosporine on the survival of Hip1-transfected
cells. These drugs caused cell death in non-transfected cells
(Fig. 1B). Treatment of Hip1-transfected cells with etoposide
and staurosporine augmented the amount of cell death caused
by Hip1 transfection alone (Fig. 1B). This indicates that upreg-
ulation of intracellular Hip1 levels leads to cell death in neuro-
nal H19-7 cells.
3.2. Digestion of Hip1 occurs during cell death
Next, we examined changes in endogenous Hip1 levels dur-
ing neuronal cell death caused by apoptosis-inducing drugs.ETO
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Fig. 2. Proteolytic processing of Hip1 into the smaller fragment occurs
in response to toxic stimuli and/or Hip1 transfection. (A) After cells
were treated with either 100 lM etoposide or 1 lM staurosporine for
the indicated times, Western blot analysis of cell lysates was performed
with anti-Hip1 antibodies. A ﬁlled arrow head denotes the intact Hip1
while as empty arrow head marks its fragment. (B) After transient
transfection with 1 lg Hip1 plasmid for the indicated times, cells were
stimulated with etoposide (ETO) or staurosporine (STS) for the
indicated times. (C) Where speciﬁed, cells were transfected with 1 lg of
Hip1 plasmid alone for 12 h or co-transfected with the increasing dose
of plasmid encoding non-toxic huntingtin (wHT) for 30 h. The levels of
Hip1 and HT in each sample were analyzed by Western blotting with
anti-Hip1 and anti-HT antibodies, as indicated. (D) Where indicated,
cells were either mock-transfected or transfected with 1 lg of Hip1
plasmid, 5 lg of wild type HT plasmid alone, or both together for 24 h.
The cell viability in each sample was then measured by MTT extraction
method (**P < 0.01 vs. control, *P < 0.05).The mitochondrial apoptotic inducer staurosporine, a potent
protein kinase inhibitor, causes apoptosis by directly stimu-
lating cytochrome c release from mitochondria. Etoposide is
a DNA-damaging anticancer drug. Etoposide-induced apop-
tosis is also executed through the mitochondrial apoptotic
pathway. Levels of Hip1 were assessed using Western blot
analyses. In the absence of apoptosis-inducing drugs, the lev-
els of Hip1 are high (Fig. 2A). This is consistent with a pre-
vious ﬁnding that Hip1 expression is detected very early in
undiﬀerentiated embryonic stem cells prior to neuronal diﬀer-
entiation [7].
Application of apoptosis-inducing drugs did not result in a
signiﬁcant change of Hip1 expression. Interestingly, 4–24 h
after stimulation with the drugs, wild type 110 kDa Hip1
was digested proteolytically into 65 kDa fragment (Fig. 2A).
We then examined fragmentation of Hip1 still occurs after
transfection of Hip1 in the absence or presence of apoptosis-
inducing drugs. As shown in Fig. 2B, Hip1 overexpression re-
sulted in proteolysis of Hip1 in the presence or absence of toxic
stimuli. The presence of toxic stimuli caused fragmentation of
Hip1 to occur more rapidly (Fig. 2B). This suggests that over-
expression of Hip1 can augment the neurotoxic eﬀects of apop-
tosis-inducing agents.
Transfection of Hip1 or stimulation with toxic drugs can
vary the levels of unbound Hip1 from the soluble huntingtin
complexes without altering the total amount of Hip1 We
examined the upregulation and fragmentation of unbound
Hip1 in response to apoptotic-inducing drugs, and the contri-
bution of unbound Hip1 to the occurrence of Hip1-induced
cell death. To verify the accumulation of ‘free’ Hip1 indirectly
and to estimate its consequential toxic eﬀect on cell viability,
Hip1 was co-transfected into cells along with increasing doses
of wild type nontoxic huntingtin with 16 CAG repeats. This
nontoxic huntingtin could recruit endogenously free Hip1 into
its binding complexes (Fig. 2C).
Transfection of normal huntingtin did not produce any toxic
eﬀect in H19-7 cells (Fig. 2D). DNA fragmentation was not
detectable using TUNEL staining (data not shown). Further-
more, co-transfection of Hip1 with wild type huntingtin signif-
icantly blocked the occurrence of cell death (Fig. 2D) as well as
the generation of cleaved Hip1 proteins in a dose-dependent
manner (Fig. 2C). This eﬀect could be caused by free wild type
huntingtin binding to Hip1, thereby decreasing Hip1 cytotox-
icity. Taken together, these ﬁndings indicate that overexpres-
sion of Hip1 results in neuronal cell death, and its toxic
eﬀect could be transmitted via the upregulation of intracellular
free Hip1 levels, which leads to the subsequent fragmentation
of Hip1.
3.3. Hip1-mediated cell death occurs through the activation of
caspase-3 in H19-7 cells
To determine whether Hip1-induced neuronal cell death oc-
curs through the activation of caspase-dependent pathways,
we ﬁrstly examined the activation of caspase-3 in H19-7 cells.
We chose to investigate caspase-3 since it is the most impor-
tant eﬀector caspase. Western blot analysis performed with
anti-procaspase-3 and anti-caspase-3 IgGs indicates that over-
expression of Hip1 induced the activation of caspase-3 in
H19-7 cells (Fig. 3A). In addition, stimulation of H19-7 cells
with etoposide also signiﬁcantly increased caspase-3 activity.
This was similar to the eﬀect of ectopic Hip1 expression
(Fig. 3A). Moreover, to conﬁrm the activation of the cas-
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Fig. 4. Hip1 interacts with and activates caspase-9, but not caspase-8.
(A) Where indicated, H19-7 cells were mock-transfected (C) or
transfected with 6 lg of plasmid encoding Myc-Hip1 for 24 h. The
cells were left untreated or treated with 100 lM of etoposide for the
indicated times. After total cells were harvested, the lysates were
immunoprecipitated with either anti-caspase-8 or anti-caspase-9 IgG,
followed by immunoblotting with anti-c-Myc antibodies, as indicated.
The proper expression of transiently transfected proteins in cell lysates
was identiﬁed with Western blot analysis with anti-Myc IgGs. (B)
After transfection with 6 lg of plasmid encoding Hip1 for 24 h, cells
were stimulated with 100 lM of etoposide for the indicated times.
Total cells were harvested and the lysates were immunoblotted with
either anti-procaspase-8 or anti-procaspase-9 antibodies, as indicated.
The intact procaspase-8 and -9 are denoted as ﬁlled arrow, whereas the
cleaved procaspase-8 and -9 are marked as empty arrow head, as
indicated.
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3 was assessed in vitro by using the ﬂuorogenic caspase-3 sub-
strate. After transfection of the plasmid encoding Hip1 into
H19-7 cells, a 3.2-fold increase in caspase-3 activity was
observed, compared with mock-transfected cells (Fig. 3B).
This suggests that Hip1 induces neuronal cell death through
the activation of caspase-3. Furthermore, the transfection of
Hip1 plus etoposide potentiated the activation of caspase-3
in a synergistic way (Fig. 3B). Hip1 plus staurosporine pro-
duced a similar stimulatory eﬀect on caspase-3 (data not
shown).
3.4. Apoptosis induced by Hip1 occurs through the activation of
caspase-9
Two major pathways of the initiation of apoptotic cell death
have been well characterized. While the signals of the extrinsic
pathway transmit via the activation of caspase-8, the intrinsic
pathway depends on local events in mitochondria. The intrin-
sic pathway then results in the cytosolic release of cytochrome
c from mitochondria, Apaf-1 binding, and activation of cas-
pase-9. To determine which pathway is contributing to Hip1-
dependent activation of caspase-3, Hip1 plasmid was transfec-
ted into cells. Immunoprecipitation was performed using either
anti-procaspase-8 or anti-procaspase-9 antibodies (Fig. 4A).
Western blot analysis of immunocomplexes using anti-Hip1
antibodies showed that Hip1 selectively binds to procaspase-9, but not to procaspase-8 (Fig. 4A). Moreover, we examined
whether overexpression of Hip1 causes the activation of cas-
pase-8 and/or -9 (Fig. 4B). Western blot analysis with their
antibodies, respectively, showed that caspase-9 was signiﬁ-
cantly activated by Hip1 transfection, while caspase-8 was
not (Fig. 4B). These data show that neuronal cell death
induced by Hip1 occurs via the sequential activation of cas-
pase-9 and caspase-3, and that Hip1 directly binds to cas-
pase-9.
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Fig. 5. Hip1 induces the cytosolic release of mitochondrial apoptotic
factors, such as cytochrome c and AIF, and the depolarization of
mitochondrial membrane potential. (A) Where speciﬁed, H19-7 cells
were transfected with 6 lg of plasmid encoding Hip1 for the indicated
times. The cells were then suspended in isotonic buﬀer, homogenized,
and separated into soluble fraction (S), pellet fraction (P) by
diﬀerential centrifugation. The fractions were analyzed by Western
blot with anti-cytochrome c and anti-AIF antibodies, as indicated. The
P1 pellet contains mitochondria and the soluble (S) fraction represents
the cytosol. (B) Where indicated, cells were mock-transfected or
transfected with 1 lg of plasmid Hip1 for 12 h. Then, the cells were
untreated or treated with 1 lM staurosporine for the indicated times.
The soluble fraction was prepared by diﬀerential centrifugation, and
analyzed by Western blot with anti-cytochrome c and anti-AIF IgGs,
as indicated. (C) Cells were incubated after treatment with 1 lM of
staurosporine (STS) for 3 h (top panel) or transfection with 1 lg of
Hip1 plasmid for 12 h (lower panel), and mitochondrial membrane
potential was assayed with JC-1 ﬂuorescence. Quantiﬁcation was
determined by FACS analysis, and the presented results are represen-
tative from three independent experiments. Lines deﬁning quadrants
were arbitrarily deﬁned to highlight changes in the ﬂuorescence of the
cell populations, and percentages represent cell number in each
S.A. Choi et al. / FEBS Letters 580 (2006) 5275–5282 52793.5. Overexpression of Hip1 induces the release of cytochrome c
and apoptosis-inducing factor (AIF) as well as the
depolarization of mitochondrial membrane potential
When cells die via intrinsic apoptotic pathways, mitochon-
dria lose membrane integrity, which results in loss of mito-
chondrial membrane potential. Mitochondrial dysfunction is
followed by the formation of apoptosome and activation of
caspase-9 through the following mechanism. Loss of mito-
chondrial membrane integrity causes the release of pro-apop-
totic proteins such as cytochrome c and AIF. The resultant
apoptosome complex is comprised of cytochrome c, Apaf-1
and caspase-9. The complex induces the activation of cas-
pase-9, and then activates caspase-3. In order to determine
whether Hip1-induced apoptotic processes accompany the
alteration of mitochondrial membrane integrity, the occur-
rence of cytosolic cytochrome c release from mitochondria
was ﬁrstly examined. As shown in Fig. 5A, Western blot anal-
ysis with anti-cytochrome c antibodies showed a remarkable
increase in the cytosolic levels of cytochrome c after 8–12 h,
which is accompanied by a signiﬁcant loss in mitochondrial
fraction. Additionally, cytosolic AIF levels increased in a
time-dependent manner (Fig. 5A). Moreover, when cells were
stimulated with 1 lM of staurosporine after Hip1 transfection,
the cytosolic release of cytochrome c and AIF occurred more
rapidly, compared with the cells transfected with Hip1 alone
(Fig. 5B). Etoposide (100 lM) had a similar eﬀect on cyto-
chrome c and AIF release (data not shown).
To determine the eﬀect of Hip1 on the mitochondrial mem-
brane potential (Dwm), the ﬂuorescent carbocyanine dye JC-1
was used. The lipophilic cation JC-1 accumulates in the mito-
chondrial matrix driven by the electrochemical gradient. The
higher the Dwm, the more polarized is the mitochondrial mem-
brane, and the more JC-1 dye is taken up into the matrix. In
the cytosol, the monomeric form of the dye ﬂuoresces green
(emissions read at 527 nm), whereas highly concentrated with-
in mitochondrial matrix, JC-1 forms aggregates that ﬂuoresce
red (emissions read at 590 nm). To quantify the red ﬂuores-
cence in cells that had taken up JC-1, FACS analysis has been
performed. As shown in Fig. 5C, a two-dimensional display of
JC-1 red ﬂuorescence(y axis, 590 nm) versus green ﬂuorescence
(x axis, 527 nm) illustrates the quantitative changes in Dwm
that occur following Hip1 transfection or the addition of
staurosporine. At 0 h, cells display a baseline level of red ﬂuo-
rescence that would represent normal mitochondrial mem-
brane polarization. However, by 2 h after treatment with
1 lM staurosporine, a rise in Dwm was observed. This was indi-
cated by an increase in the number of cells in the upper two
quadrants, totaling 18.8% at time 0, versus 62.8% at 12 h
(Fig. 5C). In a similar way, transfection of Hip1 for 12 h also
led to the increase of Dwm, when compared with mock-trans-
fected control cells (Fig. 5C). These results suggest that overex-
pression of Hip1 induces neuronal cell death via mitochondrial
dysfunction and the cytosolic release of pro-apoptotic eﬀec-
tors, such as cytochrome c and AIF.quadrant.3.6. Hip1 interacts with Apaf-1 and promotes the binding of
Apaf-1 to cytochrome c
Based on the current ﬁnding that Hip1 interacts with cas-
pase-9 and -3, along with the essential role of Apaf-1 for the
activation of caspase-3 via the interaction of caspase-9, it could
be speculated that Hip1 also directly interacts with Apaf-1. Tovalidate this possibility, the plasmid encoding Myc-tagged
Hip1 was transiently transfected into cells, followed by immu-
noprecipitation with an anti-Myc antibody. The immunopre-
cipitates were examined by Western blot analysis with anti-
Apaf-1 antibodies. As shown in Fig. 6A, Hip1 directly bound
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Fig. 6. Hip1 directly interacts with Apaf-1 and is involved in the formation of apoptosome. (A) H19-7 cells were mock-transfected or transfected
with 6 lg of plasmid encoding Myc-Hip1, as indicated. After 24 h, total cells were fractionated and the cytosolic fraction was immunoprecipitated
with anti-c-Myc IgG, followed by blotting with anti-Apaf-1 antibody. (B) Where indicated, recombinant GST-Hip-1 and GST protein were prepared.
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as indicated.
5280 S.A. Choi et al. / FEBS Letters 580 (2006) 5275–5282to Apaf-1. In addition, the interaction between Hip1 and
Apaf-1 was conﬁrmed by using recombinant GST-Hip1 and
in vitro pull-down assay. After cells were stimulated with
staurosporine, cell lysates were prepared and immunoprecipi-
tated with anti-Apaf-1 IgGs. As shown in Fig. 6B, anti-
Apaf-1 immunocomplexes well bound to GST-Hip1, but not
to GST alone, suggesting that Hip1 is functionally linked to
neuronal cell death via binding to Apaf-1.
Next we examined whether released cytochrome c binds to
Apaf-1. It is known that, as the formation of binding complex
between cytochrome c and Apaf-1 generates the more wide-
open conformation of Apaf-1, binding of deoxy-ATP or
ATP to the CARD consequently allows for the multimeriza-
tion of Apaf-1 and its association with procaspase-9. This re-
sults in generation of an apoptosome complex having about
1.0 MDa size, consisting of cytochrome c/Apaf-1/caspase-9
[24,25]. After the transient transfection of Hip1 plasmid, cells
were fractionated to separate subcellular compartments. The
cytosolic fraction was immunoprecipitated with anti-Apaf-1
IgG, followed by immunoblotting with anti-cytochrome c
antibodies. As shown in Fig. 6C, Apaf-1 was bound to cyto-
chrome c, indicating that overexpression of Hip1 induces theformation of cytosolic binding complex between cytochrome
c and Apaf-1.
Furthermore, the possibility that Hip1 might play a role in
making an apoptosome complex between caspase-9 and
Apaf-1 was validated by assessing whether binding between
caspase-9 and Apaf-1 occurs after transfection of Hip1 into
H19-7 cells. As shown in Fig. 6C, transient overexpression of
Hip1 induced the direct interaction between caspase-9 and
Apaf-1. Taken together, these data suggest that the cell death
signals of Hip1 are transmitted via the activation of the forma-
tion of apoptosome complex, which consists of cytochrome c,
Apaf-1, and caspase-9. Formation of the apoptosome complex
leads to the activation of caspase-3.4. Discussion
Besides the role of Hip1 in the endocytic pathway and vesicle
traﬃcking [18], there are conﬂicting data in the literature
regarding the eﬀect of Hip1 on cell viability. Originally, Hip1
was reported to function as a pro-apoptotic protein [19,26].
Although the mechanism of cell death was unclear, both
S.A. Choi et al. / FEBS Letters 580 (2006) 5275–5282 5281caspase 8-independent intrinsic and caspase 8-dependent
extrinsic death receptor ﬁnal pathways have been implicated.
The latter has been shown to be mediated by a Hip1-protein
binding partner, designated HIPPI (Hip1 protein interactor)
[26]. The current study, along with our previous study, has
shown the pro-apoptotic activity of Hip1 in hippocampal neu-
roprogenitor H19-7 cells [20]. By contrast, mutation of murine
Hip1 in vivo leads to testicular degeneration due to apoptosis
of post-meiotic spermatids, suggesting a primary role for full-
length Hip1 in the survival of some cell types [27]. In addition,
Hip1 was reported to transform ﬁbroblasts and to be overex-
pressed in multiple cancers [28,29]. This discrepancy could be
explained by the speculation: while the normal cellular func-
tion of Hip1, such as proper endocytosis and receptor traﬃck-
ing, requires interaction with wild type huntingtin, increased
polyglutamine tracts in HT and/or structural modiﬁcation of
Hip1 could disturb the normal interaction. This diminished
interaction between Hip1 and HT could release Hip1 from
the complex. The increase in the levels of unbound free
Hip1, in turn, could lead to alteration of biochemical events
at the membrane causing premature cell death and, ultimately,
the clinical manifestations of HD.
This prediction was supported by the ﬁnding that intact
Hip1 can be processed into fragment after either Hip1 overex-
pression or stimulation with apoptosis-inducing drugs. These
events results in the inhibition of normal Hip1-mediated pro-
tein transport and, subsequently, induction of cell death. In
addition, co-expression of Hip1 with a normal huntingtin frag-
ment capable of binding Hip1 was shown signiﬁcantly to re-
duce Hip1-induced cell death [19]. Furthermore, transfection
of Hip1 deletion mutants leads to the induction of apoptosis
in multiple cell types, including HEK293T cells [28,29].
Although the regulation of Hip1 expression and the mecha-
nism by which it is increased in tumors is largely unknown, the
levels of Hip1 were unaﬀected by the expression of polygluta-
mine-expanded huntingtin in transgenic mice and in HD pa-
tient brain samples [7]. The present study also demonstrates
that while the total amount of endogenous Hip1 was not chan-
ged at all, overepxression of Hip1 alone or with stimulation by
toxic stimuli caused the digestion of intact Hip1 into its partial
fragment. In addition, increase in the levels of wild type hun-
tingtin also blocked the occurrence of cell death as well as
the generation of cleaved Hip1 proteins. This suggests that
wild type huntingtin might bind to Hip1 in the cells, which de-
creases Hip1 toxicity. Fragmentation of Hip1 appears to con-
tribute the Hip1-induced neuronal cell death.
Additionally, there are several lines of evidence to suggest
that overexpression of normal HT provides resistance to cell
death, as would be predicted if wild-type huntingtin sequesters
Hip1 and prevents it from inducing the apoptotic pathway.
Rigamonti et al. demonstrated that expression of wild-type
HT protected clonal striatal derived cells from several apopto-
tic stimuli [30]. Furthermore, increasing the expression of wild-
type HT in transgenic mice protects against the toxic eﬀects of
mutant huntingtin, potentially by binding to Hip1 [31].
Additional elucidation of the signaling pathways revealed
that apoptotic signals of Hip1 transmit through the intrinsic
mitochondrial pathways via the activation of caspase-9 and
the formation of the apoptosome complex. The involvement
of the intrinsic apoptotic pathway in Hip1-induced cell death
was implicated by a previous report that apoptosis mediated
by the deletion mutant of Hip1 is inhibited by a dominant-neg-ative caspase-9 [28]. Further studies can search for the un-
known extra-binding partners of Hip1 in CNS neuronal
cells. For example, an interaction between the death eﬀector
domain-containing proteins Hip1 and Hip1-protein interactor
(Hippi) induces the oligomerization and activation of caspase-
8. This subsequently leads to mammalian cell death [26]. Based
on that report, it will be also interesting to test whether the
Hip1/Hippi interaction occurs under the current conditions
of neuronal cell death in H19-7 cells. These studies will help
us to understand the functional role of Hip1 and its links to
the pathogenesis of HD and other neurodegenerative diseases.
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